Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Ailin Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5162-9499; OpenAlex author ID A5006997102, A5088120617. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2017: 4 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. M1 Macrophage-Derived Extracellular Vesicles Loaded with CX3CR1 siRNA for the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsami.5c07950↗
  2. Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis. Co-author DOI 10.1186/s12014-024-09522-4↗
  3. Oral mycobiota and pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-022-10329-5↗
  4. Symptom evaluation in pancreatic cancer detection. First author DOI 10.1016/j.asjsur.2021.08.028↗
  5. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer. First author DOI 10.1186/s13148-020-00898-2↗
  6. Oral microbiome and pancreatic cancer. Co-author DOI 10.3748/wjg.v26.i48.7679↗
  7. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ijsu.2017.10.065↗
  8. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN. Co-author DOI 10.1016/j.yexcr.2017.10.033↗
  9. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Co-author DOI 10.18632/oncotarget.22494↗
  10. [Expression of TWEAK/Fn14 in Pancreatic Cancer]. Co-author PMID 28612578↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ang Li · 3 shared papers, 2020–2024 · strength 0.55
  2. Mei Rosemary Fu · 3 shared papers, 2020–2022 · strength 0.43
  3. Jue Yuan · 3 shared papers, 2020–2021 · strength 0.39
  4. Yi Jin · 1 shared paper, 2024 · strength 0.26
  5. Yong Zhang · 1 shared paper, 2024 · strength 0.26
  6. Jiaolin Wen · 1 shared paper, 2025 · strength 0.25
  7. Miao Cheng · 1 shared paper, 2025 · strength 0.25
  8. Junjie Xiong · 3 shared papers, 2017 · strength 0.21
  9. Nengwen Ke · 2 shared papers, 2017 · strength 0.14
  10. Xu-Bao Liu · 2 shared papers, 2017 · strength 0.13
  11. Weiming Hu · 2 shared papers, 2017 · strength 0.13
  12. Dan Wang · 2 shared papers, 2017 · strength 0.13
  13. Shu Gong · 1 shared paper, 2017 · strength 0.12
  14. Hongying Liu · 1 shared paper, 2020 · strength 0.10
  15. Feng Cao · 1 shared paper, 2020 · strength 0.10
  16. Li Mao · 1 shared paper, 2020 · strength 0.10
  17. Ang Li · 1 shared paper, 2020 · strength 0.10
  18. Zhenlu Li · 1 shared paper, 2020 · strength 0.10
  19. Xubao Liu · 1 shared paper, 2017 · strength 0.07
  20. Ang Li · 1 shared paper, 2017 · strength 0.06
  21. Chunlu Tan · 1 shared paper, 2017 · strength 0.06
  22. Huimin Lü · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.